These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20972202)

  • 1. 14-3-3 protein detection and sporadic CJD: the status quo serves well while awaiting progress.
    Collins SJ; McGlade A; Boyd A; Masters CL; Klug GM
    J Neurol Neurosurg Psychiatry; 2010 Nov; 81(11):1181. PubMed ID: 20972202
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison Between Sporadic and Misdiagnosed Sporadic Creutzfeldt-Jakob Disease: A Report of Two Cases.
    Zhao X; Yu Y; Zhao Z; Xu J
    Cell Biochem Biophys; 2015 Jun; 72(2):311-5. PubMed ID: 25556070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
    Van Everbroeck B; Boons J; Cras P
    Clin Neurol Neurosurg; 2005 Aug; 107(5):355-60. PubMed ID: 16023527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion disease: diagnostic value of cerebrospinal fluid markers.
    Parchi P; Capellari S
    Nat Rev Neurol; 2013 Jan; 9(1):10-1. PubMed ID: 23208112
    [No Abstract]   [Full Text] [Related]  

  • 5. [New investigations in suspected Creutzfeldt-Jakob disease. Analysis of 14-3-3 protein and T-tau in cerebrospinal fluid for safer diagnosis].
    Zetterberg H; Hammarin AL; Nilsson P; Andersson E; Lind B; Blennow K
    Lakartidningen; 2005 Mar 21-Apr 3; 102(12-13):956-8, 960-1. PubMed ID: 15887642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review.
    Chohan G; Pennington C; Mackenzie JM; Andrews M; Everington D; Will RG; Knight RS; Green AJ
    J Neurol Neurosurg Psychiatry; 2010 Nov; 81(11):1243-8. PubMed ID: 20855493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF Tau proteins reduce misdiagnosis of sporadic Creutzfeldt-Jakob disease suspected cases with inconclusive 14-3-3 result.
    Leitão MJ; Baldeiras I; Almeida MR; Ribeiro MH; Santos AC; Ribeiro M; Tomás J; Rocha S; Santana I; Oliveira CR
    J Neurol; 2016 Sep; 263(9):1847-61. PubMed ID: 27357003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Korean patients with suspected Creutzfeldt-Jakob disease with 14-3-3 protein in cerebrospinal fluid: Preliminary study of the Korean Creutzfeldt-Jakob disease active surveillance program.
    Lim JS; Kwon HM; Jang JW; Ju YR; Kim S; Park YH; Park SY; Kim S
    Prion; 2015; 9(2):136-43. PubMed ID: 25996401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease.
    Llorens F; Zafar S; Ansoleaga B; Shafiq M; Blanco R; Carmona M; Grau-Rivera O; Nos C; Gelpí E; Del Río JA; Zerr I; Ferrer I
    Neuropathol Appl Neurobiol; 2015 Aug; 41(5):631-45. PubMed ID: 25134744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in diagnosing Creutzfeldt-Jakob disease with MRI and CSF 14-3-3 protein analysis.
    Zeidler M; Green A
    Neurology; 2004 Aug; 63(3):410-1. PubMed ID: 15304568
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic value of CSF 14-3-3 detection in sporadic CJD diagnosis according to the age of the patient.
    Peoc'h K; Delasnerie-Lauprêtre N; Beaudry P; Laplanche JL
    Eur J Neurol; 2006 Apr; 13(4):427-8. PubMed ID: 16643327
    [No Abstract]   [Full Text] [Related]  

  • 12. CSF BACE1 activity is increased in CJD and Alzheimer disease versus [corrected] other dementias.
    Holsinger RM; Lee JS; Boyd A; Masters CL; Collins SJ
    Neurology; 2006 Aug; 67(4):710-2. PubMed ID: 16924032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease.
    Dorey A; Tholance Y; Vighetto A; Perret-Liaudet A; Lachman I; Krolak-Salmon P; Wagner U; Struyfs H; De Deyn PP; El-Moualij B; Zorzi W; Meyronet D; Streichenberger N; Engelborghs S; Kovacs GG; Quadrio I
    JAMA Neurol; 2015 Mar; 72(3):267-75. PubMed ID: 25559883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.
    Sanchez-Juan P; Green A; Ladogana A; Cuadrado-Corrales N; Sáanchez-Valle R; Mitrováa E; Stoeck K; Sklaviadis T; Kulczycki J; Hess K; Bodemer M; Slivarichová D; Saiz A; Calero M; Ingrosso L; Knight R; Janssens AC; van Duijn CM; Zerr I
    Neurology; 2006 Aug; 67(4):637-43. PubMed ID: 16924018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cerebrospinal fluid markers of prion diseases].
    Golańska E; Gresner S; Sieruta M; Liberski P
    Neurol Neurochir Pol; 2008; 42(5):441-50. PubMed ID: 19105113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased detection of 14-3-3 protein in cerebrospinal fluid in Sporadic Creutzfeldt-Jakob Disease during the disease course.
    Giraud P; Biacabe AG; Chazot G; Later R; Joyeux O; Moene Y; Perret-Liaudet A
    Eur Neurol; 2002; 48(4):218-21. PubMed ID: 12422071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normalization of 14-3-3 in CJD.
    Schrooten M; De Vooght W; Weckhuysen S; Van Paesschen W; Van Damme P
    Acta Neurol Belg; 2008 Jun; 108(2):64-6. PubMed ID: 18795599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical presentation of Creutzfeldt-Jakob disease: a rare but important cause of rapidly progressive dementia.
    Taillefer MS; Tangarorang GL; Kuchel GA; Menkes DL
    Conn Med; 2011 Sep; 75(8):473-8. PubMed ID: 21980678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sporadic Creutzfeldt-Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3γ assay.
    Leitão MJ; Baldeiras I; Almeida MR; Ribeiro MH; Santos AC; Ribeiro M; Tomás J; Rocha S; Santana I; Oliveira CR
    Neuroscience; 2016 May; 322():398-407. PubMed ID: 26940479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analyses of 14-3-3 protein in the cerebrospinal fluid in Creutzfeldt-Jakob disease. Preliminary report].
    Golańska E; Hułas-Bigoszewska K; Sikorska B; Liberski PP
    Neurol Neurochir Pol; 2005; 39(5):358-65. PubMed ID: 16273459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.